Connect Biopharma Holdings Limited (CNTB)
NASDAQ: CNTB · Real-Time Price · USD
0.980
-0.070 (-6.66%)
Nov 21, 2024, 10:45 AM EST - Market open
CNTB Employees
Connect Biopharma Holdings had 81 employees as of December 31, 2023. The number of employees decreased by 19 or -19.00% compared to the previous year.
Employees
81
Change (1Y)
-19
Growth (1Y)
-19.00%
Revenue / Employee
$297,728
Profits / Employee
-$263,951
Market Cap
54.15M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 81 | -19 | -19.00% |
| Dec 31, 2022 | 100 | -8 | -7.41% |
| Jan 1, 2022 | 108 | 46 | 74.19% |
| Dec 31, 2020 | 62 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| 111, Inc. | 1,520 |
| Singular Genomics Systems | 255 |
| Enzo Biochem | 136 |
| Vicarious Surgical | 131 |
| Prelude Therapeutics | 128 |
| DBV Technologies | 105 |
| Aadi Bioscience | 89 |
| Shattuck Labs | 75 |
CNTB News
- 5 weeks ago - Attovia Therapeutics Appoints Chief Financial Officer - GlobeNewsWire
- 6 weeks ago - CNTB Stock Dips Amid Biotech Sector Volatility - GuruFocus
- 7 weeks ago - CNTB Stock Surges Over 5% Amid Strong Financial Performance - GuruFocus
- 2 months ago - Connect Biopharma Reports First Half 2024 Financial Results and Provides Business Update - GlobeNewsWire
- 5 months ago - Connect Biopharma to Participate in the Leerink Partners I&I and Metabolism Therapeutics Forum - GlobeNewsWire
- 5 months ago - Connect Biopharma Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 5 months ago - Connect Biopharma Announces New Leadership and Chair of the Board of Directors - GlobeNewsWire
- 6 months ago - Connect Biopharma Presents Late-Breaking Abstract at the American Thoracic Society 2024 International Conference on the Positive Rademikibart Data from its Global Phase 2b in Patients with Moderate-to-Severe Asthma - GlobeNewsWire